AbbVie, Inc. is a global, research-based biopharmaceutical company that employs more than 28,000 people worldwide and markets medicines in more than 170 countries (abbvie.com).
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds.
C2N Diagnostics works with multiple academic centers to test new scientific ideas and provide important contributions to the field.
NIA, one of the 27 Institutes and Centers of NIH, leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. NIA is the primary Federal agency supporting and conducting Alzheimer’s disease research.
C2N Diagnostics partners with leading disease research foundations to bridge critical translational gaps in funding and science. These foundations provide generous capital resources, domain knowledge, and community networks to accelerate C2N’s efforts.
If you are interested in partnering with C2N, please contact us.